Steven L. Walker
Papers
2
Total Citations
150
H-Index
2
About
Steven L. Walker is a pioneering researcher in chemical biology and regenerative medicine, best known for developing high-throughput in vivo screening platforms using zebrafish. His major contributions center on overcoming traditional bottlenecks in drug discovery by enabling whole-organism chemical screens at unprecedented scale. Walker’s landmark 2015 study, cited over 100 times, introduced the first quantitative high-throughput screen in zebrafish, identifying novel pathways to increase pancreatic β-cell mass—a critical breakthrough for diabetes research. He further advanced the field with the ARQiv-HTS platform (2016, 50 citations), a versatile system that achieves in vivo drug discovery rates comparable to in vitro assays. By integrating automation with zebrafish biology, Walker’s work has transformed how researchers identify therapeutic compounds, bridging the gap between cellular assays and whole-organism efficacy. His achievements include pioneering methods that reduce false positives from cell-based screens and enable direct observation of complex physiological responses. For students and researchers, Walker exemplifies how innovative tool-building can accelerate the discovery of treatments for metabolic diseases and beyond.
Research Focus
Key Achievements
Top Papers
- 1
- 2